De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You
Recruiting now
Conditions studied: Breast Cancer
In brief
This is a live biobank study for breast cancer (BC) patients where samples will be collected at inflection points in the course of the disease.
Key facts
- Study ID
- NCT05134779
- Run by
- Weill Medical College of Cornell University
- People needed
- 400
- Starts
- 2022-01-12
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2025-12-18
Who can join
Age: 18 and older, up to 90. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- All patients will historically proven BC are eligible to be on the study
You may not qualify if…
- Carriers of other cancers other than breast.
Where it is running
- Brooklyn Methodist Hospital - NewYork Presbyterian — New York, New York, United States (enrolling)
- New York Presbyterian Hospital - Queens — New York, New York, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.